Skip to main content
Edwards Lifesciences Logo

KONECT RESILIA aortic valved conduit

KONECT RESILIA aortic valved conduit

The first real-world multicenter study of bio-Bentall procedures with a novel pre-assembled aortic valved conduit1

Study sites

Study sites

Weill Cornell Medical Center | Cleveland Clinic  | Hospital of the University of Pennsylvania

Number of patients

Number of patients

329 patients

Aortic valve etiology

Aortic valve etiology

Aortic aneurysm, aortic dissection, endocarditis, and valvular dysfunction

Outcomes at one year — multicenter series1

100%

freedom from valve-related death

99.6%

freedom from aortic valve or root operation at one year

94.9%

freedom from all-cause mortality  at one year

98.5%

freedom from cardiovascular death at one year

Single-center retrospective study of adults undergoing elective bio-Bentall procedures with KONECT RESILIA aortic valved conduit2

Study sites

Study site

Yale School of Medicine, Division of Cardiac Surgery

Number of patients

Number of patients

118 patients

Study years

Study years

2021-2023

Low operative and short-term mortality

Low operative and short-term mortality

Median length of stay: 6.5 days

Median length of stay: 6.5 days

Initial findings suggest the KONECT RESILIA aortic valved conduit may offer favorable early outcomes for patients undergoing aortic root and valve replacement.

Konect resilia aortic valved conduit

Outcomes at 7 years3

Outcomes at 7 years3

KONECT RESILIA aortic valved conduit is built on the 
Carpentier-Edwards PERIMOUNT valve platform, whose performance is backed by a span of 30 years of published clinical data.

Data on valves with RESILIA tissue from the COMMENCE aortic trial show excellent outcomes through 7 years.

99.3%

freedom from structural valve detorioration3

97.2%

freedom from reoperation3

85.4%

freedom from all-cause mortality3

30,000+ patients

have been treated with the KONECT aortic valved conduit globally

500,000+ patients

have been treated with RESILIA tissue devices

Global map

KONECT RESILIA aortic valved conduit brochure

Download brochure
KONECT RESILIA aortic valved conduit brochure

References

  1. Roselli E, Girardi L, Desai N, et al. First real-world multicenter series of bio-Bentall procedures with a novel pre-assembled aortic valved conduit. Podium presentation at: European Association for Cardiothoracic Surgery; October 8-11 2025; Copenhagen, Denmark. Accessed October 09.2025.
  2. Erez E, Dankwa S, Higaki A, et al. Clinical, physiologic, and anatomic outcomes of a new bioprosthetic aortic valved conduit: 1-year outcomes. Presented at: 61st Annual Meeting of the Society of Thoracic Surgeons (STS 2025); January 26, 2025; Los Angeles, CA. Available at: https://sts2025.eventscribe.net/fsPopup.asp?PresenterID=1746287&mode=posterPresenterInfo
  3. Beaver T, Bavaria JE, Griffith B, et al. Seven-year outcomes following aortic valve replacement with a novel tissue bioprosthesis. J Thorac Cardiovasc Surg. 2024;168(3):781-791. doi:10.1016/j.jtcvs.2023.09.047
Medical device for professional use

Medical device for professional use

For a listing of indications, contraindications, precautions, warnings, and potential adverse events, please refer to the Instructions for Use (consult eifu.edwards.com where applicable).

PP--EU-10323 v1.0